The present invention provides 4-amino-6- substituted-hexahydrobenz[cd]indoles which are useful in treating disease states which can be benefited by an alteration of function at 5-HT1A receptors.
申请公布号
CA2037100(C)
申请公布日期
2003.10.21
申请号
CA19912037100
申请日期
1991.02.26
申请人
ELI LILLY AND COMPANY
发明人
FLAUGH, MICHAEL E.;FOREMAN, MARK M.;MARTINELLI, MICHAEL J.;KRESS, THOMAS J.;LEANNA, MARVIN R.;PETERSON, BARRY C.
